Hong Li

Dr. Hong Li


Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2019 in World Allergy Organization Journal
Verified
Journal Article
Open access
YXYingyang Xu
Yingyang Xu
NJNan-Nan Jiang
Nan-Nan Jiang
LWLi-Ping Wen
Li-Ping Wen
HLHong Li
Hong Li
JYJia Yin
Jia Yin
Clinical observation revealed that most of wheat-induced anaphylaxis (WIA)/wheat-dependent exercise-induced anaphylaxis (WDEIA) patients showed a history of recurrent urticaria. We aim to determine the association between recurrent urticaria and anaphylaxis in wheat allergy. Population-based cohort study involved patients with WIA (n = 193, including WDEIA n = 104), recurrent urticaria (n = 177), non-wheat-related anaphylaxis (n = 584), atopic disease (excluding anaphylaxis, n = 221) and healthy control (n = 95) from 2009 to 2016. Detailed course of urticaria and anaphylaxis were obtained from medical records and following-up questionnaire. Serum IgE specific to wheat, gluten and ω-5 gliadin and skin prick test to wheat were examined. Clinical and laboratory data were statistically analyzed. In recurrent urticaria patients, wheat allergy was not rare, and 6.8% (n = 12) was diagnosed as wheat-induced urticaria. Patients with WIA/WDEIA had higher prevalence of recurrent urticaria history than those with non-wheat-related anaphylaxis (164/193, 84.9% vs 85/584, 14.5%), and 70.4% of them (136/193) had recurrent urticaria prior to their first anaphylactic attack. Among patients with WIA/WDEIA and previous urticaria, 46.3% experienced an exacerbation of urticaria. The value of serum specific IgE to ω-5 gliadin was significantly higher in patients with WIA/WDEIA than those with wheat-induced urticaria. We recommend screening wheat allergy in recurrent urticaria to identify patients who have a potential risk to develop severe reactions earlier.

28 July 2022 in Frontiers in Immunology
Verified
Journal Article
Open access
RTRui Tang
Rui Tang
SLShubin Lei
Shubin Lei
LZLiping Zhu
Liping Zhu
YLYuzhen Lv
Yuzhen Lv
HLHong Li
Hong Li
Background: Allergic rhinoconjunctivitis (ARC) is an allergic disease that is characterized by conjunctival and nasal symptoms such as edema and congestion of conjunctiva, rhinorrhea, sneezing, and blocked nose. Seasonal ARC (SARC) is usually induced by seasonal allergens and often occurs at specific times during the year. Traditional treatments of SARC include nasal corticosteroids, antihistamines, and mast cell membrane stabilizers. Biological agents such as omalizumab have also been proved effective in the treatment of SARC.Objectives: We aim to certify the preventative efficacy of omalizumab for SARC and explore its influence factors.Methods: Medical records of 64 SARC patients were retrospectively analyzed, and generalized linear models were used to analyze influence factors of efficacy of omalizumab.Results: Compared with forepassed pollen season without omalizumab treatment, the combined symptom and medication score (CSMS) of ARC with pre-seasonal omalizumab was significantly lower (with omalizumab: 0.67[0.00,1.83], without omalizumab: 4.00[2.83,4.96], p0.05).Conclusion: Pre-seasonal omalizumab treatment could significantly relieve SARC related symptoms and reduce medication use. This preventative efficacy would not be influenced by the dosage and number of injections of omalizumab. A single dose of 150mg omalizumab could achieve a satisfactory outcome.

19 February 2021 in Clinical Reviews in Allergy & Immunology
Verified
Journal Article
Closed access
PDF file
YSYue Shi
Yue Shi
RTRui Tang
Rui Tang
FLFangmei Luo
Fangmei Luo
HLHong Li
Hong Li
ZPZhouxian Pan
Zhouxian Pan
TPThomas A. Platts-Mills
Thomas A. Platts-Mills

14 May 2013 in Internal Medicine Journal
Verified
Journal Article
Closed access
PDF file
YSY. Song
Y. Song
JLJ. Liu
J. Liu
HLHong Li
Hong Li
ZZZ. Zeng
Z. Zeng
XBX. Bian
X. Bian
SWS. Wang
S. Wang

30 June 2023 in Chinese Medical Sciences Journal
Verified
Journal Article
Open access
PDF file
LZLi-Ping Zhu
Li-Ping Zhu
RTRui Tang
Rui Tang
QWQing Wang
Qing Wang
HLHong Li
Hong Li
Food-dependent, exercise-induced anaphylaxis (FDEIA) is a potentially life-threatening disorder that often occurs with exercise, and patients typically have eaten a specific food within hours before disease onset. This disease is exceedingly rare, with a prevalence of 0.02%. No well-recognized prevention or treatment strategy has been available for FDEIA except avoiding triggers strictly. Here we report an 11-year-old boy with a history of recurrent anaphylaxis of unknown etiology more than 10 times within two years. As the anaphylactic symptoms had not been controlled after traditional treatments, the patient was given subcutaneous injection of dupilumab seven times within 33 weeks. During dupilumab treatments, the patient was exposed to culprit mushrooms plus exercises at least twice a month but without notable anaphylaxis. Thus, Dupilumab may improve the allergic reactions in FDEIA patients.

29 March 2024 in Journal of Agricultural and Food Chemistry
Verified
Journal Article
Open access
JHJing Hu
Jing Hu
LZLi-Ping Zhu
Li-Ping Zhu
RWRui-Qi Wang
Rui-Qi Wang
LZLixia Zhu
Lixia Zhu
FCFeng Chen
Feng Chen
Tengchuan JinTengchuan Jin
Tengchuan Jin
Protein from Sichuan peppers can elicit mild to severe allergic reactions. However, little is known about their allergenic proteins. We aimed to isolate, identify, clone, and characterize Sichuan pepper allergens and to determine its allergenicity and cross-reactivities. Sichuan pepper seed proteins were extracted and then analyzed by SDS-PAGE. Western blotting was performed with sera from Sichuan pepper-allergic individuals. Proteins of interest were purified using hydrophobic interaction chromatography and gel filtration and further analyzed by analytical ultracentrifugation, circular dichroism spectroscopy, and mass spectrometry (MS). Their coding region was amplified in the genome. IgE reactivity and cross-reactivity of allergens were evaluated by dot blot, enzyme-linked immunosorbent assay (ELISA), and competitive ELISA. Western blot showed IgE binding to a 55 kDa protein. This protein was homologous to the citrus proteins and has high stability and a sheet structure. Four DNA sequences were cloned. Six patients' sera (60%) showed specific IgE reactivity to this purified 11S protein, which was proved to have cross-reactivation with extracts of cashew nuts, pistachios, and citrus seeds. A novel allergen in Sichuan pepper seeds, Zan b 2, which belongs to the 11S globulin family, was isolated and identified. Its cross-reactivity with cashew nuts, pistachios, and citrus seeds was demonstrated.